DNM2 and neoplasm: Numerous studies are now available demonstrating the interest of DNM2 as a biomarker for prognosis of tumor invasion and metastasis, as exemplified for cervical cancers, or to predict therapy efficacy as shown in a sub-group of breast cancer.